SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008747
Filing Date
2022-05-13
Accepted
2022-05-13 16:02:21
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220331x10q.htm   iXBRL 10-Q 1117983
2 EX-31.1 tmb-20220331xex31d1.htm EX-31.1 18443
3 EX-31.2 tmb-20220331xex31d2.htm EX-31.2 18501
4 EX-32.1 tmb-20220331xex32d1.htm EX-32.1 8287
5 EX-32.2 tmb-20220331xex32d2.htm EX-32.2 8775
  Complete submission text file 0001558370-22-008747.txt   4974610

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220331.xsd EX-101.SCH 37879
7 EX-101.CAL tmb-20220331_cal.xml EX-101.CAL 41519
8 EX-101.DEF tmb-20220331_def.xml EX-101.DEF 128126
9 EX-101.LAB tmb-20220331_lab.xml EX-101.LAB 300773
10 EX-101.PRE tmb-20220331_pre.xml EX-101.PRE 240765
50 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220331x10q_htm.xml XML 775907
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 22922549
SIC: 2834 Pharmaceutical Preparations